Tyler Smith

Tyler Smith is a Scientist I specializing in RNA technology development at Life Edit Therapeutics since October 2023. Previously, at Enumera Molecular from August 2022 to August 2023, Tyler focused on developing assays and diagnostic tools for women's health using a biochemistry, microbiology, and organic chemistry approach. As a PhD candidate at the University of Michigan from August 2017 to August 2022, Tyler designed an in vitro assay to investigate protein synthesis mechanisms, studying tRNA modifications and their effects on translation efficiency and accuracy. Tyler holds a Doctor of Philosophy in Biochemistry from the University of Michigan and a Bachelor of Science in Chemistry from Truman State University.